Top-News
Tabak/Cannabis Kanada

Cannara Biotech Inc News

Aktie
WKN:  A3D495 ISIN:  CA13765U2002 US-Symbol:  LOVFF
0,52 €
+0,003 €
+0,58%
14:29:35 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
90,02 Mio.
Marktkapitalisierung *
49,70 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 29.02.2024

Cannara Biotech Inc News

29.04.24 - PR Newswire
Cannara Biotech Reports Q2 2024 Financial Results
Cannara Biotech Reports Q2 2024 Financial Results PR Newswire
30.01.24 - PR Newswire
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion
Cannara Biotech Announces Record-​Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion PR Newswire
08.01.24 - PR Newswire
Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")
Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG") PR Newswire
13.12.23 - PR Newswire
Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024
Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024 PR Newswire
11.12.23 - PR Newswire
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023 PR Newswire
07.12.23 - PR Newswire
Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues
Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues PR Newswire
27.07.23 - PR Newswire
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million PR Newswire
11.05.23 - PR Newswire
Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference
Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference PR Newswire
04.05.23 - PR Newswire
CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING
CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-​DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING PR Newswire
25.04.23 - PR Newswire
Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023
Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023 PR Newswire
24.04.23 - PR Newswire
Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022
Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022 PR Newswire
10.02.23 - PR Newswire
CANNARA BIOTECH INC. ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING AND CONVERSION INTO EQUITY OF A $5M CONVERTIBLE DEBENTURE AT $0.18 CENT PER COMMON SHARE
CANNARA BIOTECH INC. ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING AND CONVERSION INTO EQUITY OF A $5M CONVERTIBLE DEBENTURE AT $0.18 ...
23.01.23 - PR Newswire
Cannara Biotech Inc. Reports Q1 2023 Financial Results
Cannara Biotech Inc. Reports Q1 2023 Financial Results PR Newswire
12.01.23 - PR Newswire
Cannara Announces Proposed Share Consolidation
Cannara Announces Proposed Share Consolidation PR Newswire
30.11.22 - PR Newswire
Cannara Announces Normal Course Issuer Bid for Common Shares of the Corporation
Cannara Announces Normal Course Issuer Bid for Common Shares of the Corporation PR Newswire
25.11.22 - PR Newswire
Cannara Biotech Inc. Reports Record Q4 and 2022 Fiscal Year Financial Results
Cannara Biotech Inc. Reports Record Q4 and 2022 Fiscal Year Financial Results PR Newswire
30.09.22 - PR Newswire
Cannara Releases 14 New SKU's Across Ontario and Quebec
Cannara Releases 14 New SKU's Across Ontario and Quebec PR Newswire
20.09.22 - PR Newswire
Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of its First Vape Cartridge and Vape Accessory, Tribal G Mint and UNI Pro Ark
Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of its First Vape Cartridge and Vape Accessory, Tribal G Mint and UNI Pro Ark PR Newswire
01.09.22 - PR Newswire
Acquisition of Common Shares of Cannara Biotech Inc.
Acquisition of Common Shares of Cannara Biotech Inc. PR Newswire
10.08.22 - PR Newswire
Cannara Biotech Inc. to Host Investor Webcast on August 17th, 2022
Cannara Biotech Inc. to Host Investor Webcast on August 17th, 2022 PR Newswire

Newssuche

Videos

newspaper
08:55 Uhr -6,48%
Technical Trading: Rohöl Short Chance
Rohöl Short Typ: Turbo Open End WKN: VD4JF9 Hebel: 13 Laufzeit: OpenEnd Einstieg: Market ... Mehr »